Beth Price, M.B.A.
Price right to fill CEO role at Cancer Center
Beth Price, M.B.A., has been named to the newly created position of chief executive officer of the Vanderbilt-Ingram Cancer Center.
Price has served as oncology operations strategist for Vanderbilt-Ingram and Vanderbilt Medical Group since June 2007, where she assisted in the development and implementation of the regional market oncology strategy and served as interim business officer for the Cancer Center.
As CEO Price will be responsible for expanding quality cancer services in the Middle Tennessee market and the Southeast, enhancing Vanderbilt-Ingram's status as a top 15 National Cancer Institute-designated Comprehensive Cancer Center and providing administrative and business leadership.
She will report to Jennifer Pietenpol, Ph.D., director of Vanderbilt-Ingram, and David Posch, CEO The Vanderbilt Clinic and executive director of the Vanderbilt Medical Group.
“For the last year Beth Price has been an invaluable addition to our Cancer Center enterprise,” Pietenpol said. “She has a tremendous ability to articulate a vision, develop strategic plans and execute those plans.
“As we expand our clinical services locally and regionally, we will rely on Beth's management skills and expertise to help us offer the highest quality health care to treat cancer patients as well as develop prevention programs and long-term follow-up care for cancer survivors.”
A native of Rochester, N.Y., Price earned her Bachelor of Science degree in Health Information Management from Ithaca College, N.Y., and received her M.B.A. from Suffolk University, Boston.
“I am delighted by the opportunity to help lead the extraordinary team of professionals at Vanderbilt-Ingram Cancer Center,” Price said.
“I am impressed daily with the level of talent, commitment and compassion for patients exhibited by physicians, researchers and staff at the Cancer Center and I am looking forward to working with them to expand and refine our services to those patients and our community.”
C. Wright Pinson., M.D., M.B.A., associate vice chancellor for Clinical Affairs and Chief Medical Officer, supports Price's promotion.
“Beth Price has performed very well for VICC over the past year. She has demonstrated her expertise in this service line and her understanding of our market, as well as solving many issues and providing an important coalescing force for the leadership team and indeed all of VICC.
“She, Dr. Pietenpol and others are proving to be a very capable leadership team and I am predicting much more success,” Pinson said.
Harry Jacobson, M.D., vice chancellor for Health Affairs, agreed.
“Beth will play a critical role as we grow our clinical cancer program and more strongly align it with the research enterprise on which our exceptional reputation in cancer has been built.”
Posch said Price's background in health care business is a valuable asset.
“We are experiencing tremendous growth in the number of new cancer patients who seek care here. As we expand our services in the region, we will depend on Beth's counsel to help maintain excellence in our clinical enterprise.”
Prior to joining Vanderbilt-Ingram, Price served as chief operating officer for Sarah Cannon Research Institute in Nashville.
She spent six years in Boston as senior manager for strategy and business architecture for Accenture, a global management consulting, technology services and outsourcing company. She also served in management positions at Partners Health Care System, Massachusetts General Hospital and Roger Williams Medical Center, affiliated with Boston University School of Medicine.